These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 5281479)
1. Progressive systemic sclerosis simulating idiopathic pulmonary fibrosis. Report of a case. Charles MA Med Ann Dist Columbia; 1971 May; 40(5):313-6. PubMed ID: 5281479 [No Abstract] [Full Text] [Related]
2. [Simultaneous appearance of symptoms of circumscribed and progressive scleroderma]. Weidner F; Braun-Falco O Hautarzt; 1968 Aug; 19(8):345-50. PubMed ID: 5681966 [No Abstract] [Full Text] [Related]
3. [Two cases of intrapulmonary lymph node associated with either progressive systemic sclerosis or idiopathic pulmonary fibrosis]. Yoshitomi A; Sato A; Toyoshima M; Suganuma H; Imokawa S; Tamura R; Suda T; Yagi T; Hayakawa H; Chida K Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Sep; 33(9):1003-8. PubMed ID: 8538080 [TBL] [Abstract][Full Text] [Related]
4. [Interstitial lung manifestations in systemic scleroderma. Correlation between alveolitis, autoantibodies and clinical manifestations]. Witt C; Hiepe F; Brenke A; Romberg B; Apostoloff E Z Arztl Fortbild (Jena); 1994 Nov; 88(11):867-71. PubMed ID: 7839707 [No Abstract] [Full Text] [Related]
6. [Autopsy case of pulmonary fibrosis complicated with hypergammaglobulinemia, with special reference to sine scleroderma (without skin manifestations)]. Higuchi M; Nozawa Y; Kitamura S Nihon Rinsho; 1969 Jan; 27(1):201-6. PubMed ID: 4181418 [No Abstract] [Full Text] [Related]
12. [Lymphocytic interstitial pneumonia in Gougerot-Sjögren syndrome with scleroderma]. Allard P; Kermarec J; L'Her P; Natali F; Lebarbu M; Le Vagueresse R Ann Med Interne (Paris); 1984; 135(6):431-4. PubMed ID: 6508046 [TBL] [Abstract][Full Text] [Related]
13. Progressive systemic sclerosis. Report of a case with pulmonary involvement. Munsakul N; Areechon W J Med Assoc Thai; 1970 Feb; 53(2):148-58. PubMed ID: 5476909 [No Abstract] [Full Text] [Related]
14. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody. Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458 [TBL] [Abstract][Full Text] [Related]
16. [A case from practice (240). Progressive systemic sclerosis]. Borer H; Kulstrunk M; Steiger U Schweiz Rundsch Med Prax; 1992 Apr; 81(15):489-91. PubMed ID: 1565941 [No Abstract] [Full Text] [Related]
17. Decrease in DL,CO in systemic sclerosis correlates with acceleration of DTPA clearance. Diot E; Giraudeau B; Maillot F; Diot P Eur Respir J; 1999 Sep; 14(3):728-9. PubMed ID: 10543302 [No Abstract] [Full Text] [Related]
18. Case records of the Massachusetts General Hospital. Case 51-1965. N Engl J Med; 1965 Nov; 273(22):1210-9. PubMed ID: 5847561 [No Abstract] [Full Text] [Related]
19. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis. Yanaba K; Hasegawa M; Takehara K; Sato S J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923 [TBL] [Abstract][Full Text] [Related]
20. Progressive systemic sclerosis (scleroderma). First case report in a Nigerian. Ladipo GO Dermatologica; 1976; 153(3):196-201. PubMed ID: 190055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]